Results 91 to 100 of about 130,554 (162)
The development of lipoprotein apheresis in Saxony in the last years [PDF]
Methods Three hundred thirty-nine patients (230 men, 109 women) treated with lipoprotein apheresis in Saxony, Germany, in 2018 are described in terms of age, lipid pattern, risk factors, cardiovascular events, medication, and number of new admissions ...
Fischer, Sabine +4 more
core +1 more source
Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia
Familial hypercholesterolemia (FH) is an autosomal co-dominant disorder characterized by a marked elevation of serum low-density lipoprotein (LDL) cholesterol (LDL-C) concentration, which in turn is associated with a greatly increased risk of premature ...
Halcox, Julian P. J. +4 more
core +1 more source
, 2012 [[abstract]]"Uremic patients with hyperlipidemia are classified at high atherogenic risk due to oxidative stress induced by regular hemodialysis process (hemoincompatibility) and a high level of oxidized low-density lipoprotein (ox-LDL).
;Chen, Tung-Sheng;Liou, Show-Yih;Wu, Hsi-Chin;Tsai, Fuu-Jen;Tsai, Chang-Hai;黃志揚;HUANG, CHIH-YANG;Chang, Yen-Lin
core
Effects of lipoprotein apheresis (LA) on serum PCSK9 levels
, 2014 Objectives: PCSK9 plays an important role in the regulation of LDLcholesterol concentrations via its influence on catabolism of the LDL receptors.
Milton, Mark +8 more
core +1 more source
World apheresis registry report
, 2007 The establishment of national apheresis registries has been helpful to learn about therapeutic profiles and adverse event incidences. During 2003, the World Apheresis Registry was established and centers from all countries were invited to participate to ...
Stegmayr, Bernd, +4 more
core +1 more source
[State of the art: lipoprotein apheresis]. [PDF]
Dtsch Med Wochenschr, 2023 Schatz U, Schettler VJJ, Julius U.
europepmc +1 more source